Doehner, Hartmut; Weber, Daniela; Krzykalla, Julia et al.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with <i>NPM1</i>-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trialLANCET HAEMATOLOGY. Bd. 10. H. 7. 2023
Rausch, Johanna; Dzama, Margarita M.; Dolgikh, Nadezda et al.
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclaxHAEMATOLOGICA. Bd. 108. H. 10. 2023 S. 2837-2843
Kriegsmann, Katharina; Bittrich, Max; Sauer, Sandra et al.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB StudyTRANSFUSION MEDICINE AND HEMOTHERAPY. Bd. 50. H. 5. 2023 S. 403-416
Greco, Raffaella; Hoogenboom, Jorinde D.; Bonneville, Edouard F. et al.
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyBONE MARROW TRANSPLANTATION. 2023
Finger, S.; Wild, S.; Schulz, A. et al.
MyD88 in myeloid cells promotes angiotensin II-induced vascular inflammation and is associated with all-cause mortality and incident heart failure in humans with arterial hypertensionEUROPEAN HEART JOURNAL. Bd. 44. 2023
Haeuser, Friederike; Mittler, Jens; Hantal, Misra Simge et al.
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantationCLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023
Hartmann, Ann-Kathrin; Bartneck, Joschka; Pielenhofer, Jonas et al.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionFRONTIERS IN IMMUNOLOGY. Bd. 14. 2023
Schubert, Maria-Luisa; Bethge, Wolfgang A.; Ayuk, Francis A. et al.
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry studyBLOOD ADVANCES. Bd. 7. H. 20. 2023 S. 6191-6195
Sonneveld, Pieter; Chanan-Khan, Asher; Weisel, Katja et al.
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III TrialJOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 8. 2023 S. 1600-+
Bonifacius, Agnes; Lamottke, Britta; Tischer-Zimmermann, Sabine et al.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsJOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 12. 2023